陈翊庭最新发声！

Group 1 - The Hong Kong Stock Exchange (HKEX) has seen a significant increase in overseas investor participation in new stock subscriptions, indicating a shift in global asset allocation logic [1] - As of September 2025, the total IPO financing amount in Hong Kong reached HKD 182.9 billion, more than doubling compared to the same period in 2024, making it the leading IPO market globally [3] - The secondary market in Hong Kong also performed strongly, with an average daily trading volume of HKD 256.4 billion, a year-on-year increase of 126% [7] Group 2 - The "A+H" listing model has shown remarkable performance, with nearly half of the new stock financing amount in the first nine months coming from these listings, reflecting strong interlinkage between mainland and Hong Kong markets [5] - The mutual market access mechanism has been continuously optimized, with significant growth in both southbound and northbound trading volumes, indicating its role as a bridge for the opening of China's capital markets [9] - HKEX plans to introduce the Hang Seng Biotechnology Index futures to meet the growing demand for risk management tools in the biotechnology sector [9] Group 3 - HKEX is actively working on optimizing listing regulations and expanding mutual market access mechanisms to enhance market efficiency and promote the joint development of capital markets in Hong Kong and mainland China [10] - The exchange aims to build a competitive ecosystem for offshore RMB products, providing various asset allocation and risk hedging tools to both domestic and international investors [10]